Changzhou Sunshine Pharmaceutical Co., Ltd. has a unified social credit code/registration number of 9132041kloc-0/256419, and Gu Hanping is an enterprise legal person. At present, the enterprise is in the state of opening.
The business scope of Changzhou Sunshine Pharmaceutical Co., Ltd. is: pharmaceutical production (subject to the production scope approved by the pharmaceutical production license); Production of food additives (according to the items listed in the license); Production of feed additives and additive premixed feed (operating with license); Chemical products (trifluoroacetic acid, triamcinolone acetonide, glimepiride, glipizide, glimepiride, anastrozole, ropinirole, tiagabine, bromhexine, Osola citrate, rupatadine fumarate, olopatadine hydrochloride, benzodiazepine, carvedilol and flutramadol), pharmaceutical intermediates, UV-6544. Manufacture of 6 '- tetramethyl -4- piperidinol, butyl benzoate, p-aminobenzoic acid, ethyl p-aminobenzoate, p-dimethylaminobenzoic acid, butyl p-aminobenzoate, special accessories and equipment for textile machinery; Self-management and agency for the import and export of all kinds of goods and technologies, except those restricted or prohibited by the state. (Projects subject to approval according to law can only be operated after approval by relevant departments). In Jiangsu Province, the total registered capital of companies with similar business scope is 549.59 million yuan, and the main capital is concentrated in100-100,000 and100-50,000,000 enterprises, totaling 107. In the province, the registered capital of enterprises is excellent.
See more information and materials of Changzhou Sunshine Pharmaceutical Co., Ltd. through Baidu Enterprise Credit.